| Literature DB >> 27722066 |
He Zhang1, Yantian Ma2, Pu Liu1, Xiangkai Li1.
Abstract
EmrAB operon is known for multidrug resistance in bacteria and yet has not been reported related to heavy metal resistance or antibiotics/heavy metal co-resistance. Strain Staphylococcus aureus LZ-01 which was isolated from industrial wastewater discharging site can co-resist to 6 mM Cr(VI) and 0.75 mg/ml ampicillin. Transcriptome data showed that an emrAB operon was upregulated (1.29-folds for emrA, 2.14-folds for emrB) under 0.4 mM Cr(VI) treatment. Quantitative PCR results revealed that this operon was upregulated (1.60-folds for emrA, 2.34-folds for emrB) after 0.20 mg/ml ampicillin treatment. Mutant strain with emrA gene knockout resulted in a 0.83-folds decrease in chromate resistance, and a 0.80-folds decrease in ampicillin resistance; while emrB knockout strain resulted in a 0.33-folds decrease in chromate resistance, and a 0.60-folds decrease in ampicillin resistance. The complemented strains of both deletion mutants basically restored their resistant performance. The presence of 0.50 mM Cr(VI) induced an elevation in ampicillin resistance from 0.50 to 2.50 mg/ml in the strain LZ-01, similarly, its Cr(VI) resistance was also found to be elevated from 6 to 10 mM by 0.15 mg/ml ampicillin induction. The induction effect could be eliminated by deletion of emrA or emrB. Our results demonstrated that the chromosomal emrAB operon in Staphylococcus aureus LZ-01 was a new type of multidrug resistance system, which conferred both ampicillin and chromate resistance to host cells inhabiting polluted environments.Entities:
Keywords: Ampicillin; Chromate; Co-resistance; Staphylococcus aureus LZ-01; emrAB operon
Year: 2016 PMID: 27722066 PMCID: PMC5033799 DOI: 10.1186/s40064-016-3253-7
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
The primers, strains and plasmids used in this study
| Primers, strains and plasmids | Sequence (5′–3′) or description | Source or reference |
|---|---|---|
| Primers for qPCR (Supplied in Additional file | ||
| Primers for gene knockout (Extended sequences for overlap are marked with underline) | ||
| |
| This study |
| |
| This study |
| |
| This study |
| |
| This study |
| |
| This study |
| |
| This study |
| |
| This study |
| |
| This study |
| | AACTCACGTTAAGGGATTTTGG | This study |
| | TTTCAGGTGGCACTTTTCG | This study |
| Strains used in this study | ||
| |
| Zhang et al. ( |
| |
| Purchased from CCTCC |
| | Initial recipient for modification of reconstructed plasmids | Augustin and Götz ( |
| |
| University of Chicago |
| Δ | Δ | This study |
| Δ | Δ | This study |
| CB |
| This study |
| CA |
| This study |
| Plasmids | ||
| pMAD | pMAD is a shuttle vector used for gene knockout of | Arnaud et al. ( |
| pET-30a | pET-30a used for clone of | Purchased |
The MIC levels of antibiotics and heavy metals in different strains
| Strains | Antibiotics (mg/ml)a | Metal concentrations (mM) | ||||||
|---|---|---|---|---|---|---|---|---|
| Amp | Chlo | Cr(VI) | As(V) | Hg(II) | Pb(II) | Mn(II) | Cu(II) | |
| LZ-01 | 0.51 | 0.25 | 6 | 4 | 0.005 | 1 | 6 | 1 |
| ATCC25923 | 0.06 | 0.13 | 3 | 4 | 0.005 | 0.05 | 2 | 1 |
| Δ | 0.15 | 0.25 | 4 | 4 | 0.005 | 0.5 | 4 | 1 |
| Δ | 0.10 | 0.30 | 1 | 3 | 0.005 | 0.5 | 4 | 1 |
| CB | 0.51 | 0.26 | 5 | 4 | 0.005 | 0.5 | 6 | 1 |
| CA | o.51 | 0.26 | 5 | 4 | 0.005 | 0.5 | 5 | 1 |
aAll the data here represent consistent result of 3–5 individual tries of gradient dilution series
Fig. 1The comparison of antibiotic resistant levels between strain S. aureus LZ-01 (the upper part) and type strain S. aureus ATCC 25923 (the lower part)
Genes involved in co-resistance of Cr(VI) and ampicillin were tested by RNA-seq and qPCR methods in strain LZ-01
| Genes | Gene annotation | RNA-seq | qPCR |
|---|---|---|---|
| Multidrug transporter and resistance associated genes | |||
| SAV0198 | ABC-type antimicrobial peptide transport system | 6.21 | 0.61 |
| SAV0199 | ABC-type antimicrobial peptide transport system | 10.14 | 0.72 |
| SAV0203 | ABC-type multidrug transport system | 7.92 | 0.86 |
| SAV0274 | Drug transporter | 5.78 | 0.57 |
| SAV0275 | Penicillin amidase V | 2.96 | 0.72 |
| SAV0276 | Peptidoglycan hydrolase | 1.58 | 0.47 |
| SAV0277 | ABC-type multidrug transport system | 1.14 | 0.79 |
| SAV0351 | ABC-type multidrug transport system | 1.07 | 1.18 |
| SAV0661 | ABC-type antimicrobial peptide transport system | 1.86 | 1.19 |
| SAV1035 | ABC-type antimicrobial peptide transport system | 8.23 | 0.30 |
| SAV1318 | ABC-type multidrug transport system | 5.10 | 0.97 |
| SAV1837 | ABC-type multidrug transport system | 1.01 | 0.99 |
| SAV1866 | ABC-type multidrug transport system | 1.23 | 0.71 |
| SAV2166 | Drug resistance MFS transporter | 1.47 | 0.58 |
| SAV2168 | Putative multidrug transporter | 4.26 | 1.05 |
| SAV2169 | Multidrug ABC transporter | 3.58 | 1.01 |
| SAV2261 | Cation/multidrug efflux pump | 1.25 | 1.13 |
| SAV2262 | Uncharacterized protein involved in methicillin resistance | 1.01 | 1.12 |
| SAV2265 | Mar R family transcriptional regulator | 10.64 | 0.67 |
| SAV2266 | MFS family transporter ybf D | 6.44 | 0.63 |
| SAV2352( | Drug resistance MFS transporter, drug:H+ antiporter-2 family | 2.14 | 2.34a |
| SAV2353( | Multidrug resistance efflux pump | 1.29 | 1.60a |
| SAV2355 | Drug resistance transporter, Bcr/Cfl A subfamily | 3.60 | 0.86 |
| SAV2419 | Toxin production and resistance | 1.28 | 0.94 |
| SAV2420 | Toxin production and resistance | 1.22 | 0.94 |
| SAV2421 | Toxin production and resistance | 1.51 | 0.59 |
| SAV2428 | ABC-type multidrug transport system | 15.80 | 0.51 |
| SAV2462 | Antibiotic resistance protein | 2.13 | 0.79 |
| SAV2552 | Predicted drug exports of the RND family | 4.55 | 0.66 |
| SAV2623 | ABC-type antimicrobial peptide transport system | 1.68 | 0.96 |
| SAV2701 | ABC-type antimicrobial peptide transport system | 13.05 | 0.73 |
| SAV2702 | Similar to ABC transporter, vraE protein | 10.66 | 0.63 |
| Ampicillin-resistant genes | |||
| SAV1275 | Metallo-beta-lactamase superfamily | 0.98 | 0.80 |
| SAV1504 | Metallo-beta-lactamase | 1.02 | 0.51 |
| SAV1545 | Metallo-beta-lactamase superfamily protein | 0.74 | 1.02 |
| SAV2441 | Similar to beta-lactamase | 1.42 | 0.44 |
|
| Penicillin-binding protein 1 | 1.54 | 3.88 |
|
| Penicillin-binding protein 1A | 2.10 | 2.02 |
|
| Penicillin-binding protein 3 | 1.05 | 2.71 |
|
|
| 0.77 | 3.32 |
aStands for the selected genes for next study
Fig. 2The growth status of different strains on the TSA medium with Cr(VI) and/or ampicillin added. The control means no Cr(VI) or ampicillin was added. ATCC stands for strain S. aureus ATCC25923, LZ-01 stands for strain S. aureus LZ-01, CA and CB are complemented strains for deletion mutant strain ΔemrA and ΔemrB. Cultures of different strains were diluted to tenfold gradients. 3 µl of each gradient culture was inoculated on to plate in a line, and different strains were inoculated in a column. All the plates were incubated in 37 °C for 12–18 h
Fig. 3The growth curves of strain S. aureus LZ-01 and mutants
Fig. 4Induction effects on MICs for antibiotics and metals on strain S. aureus LZ-01. The induced level was 0.15 mg/ml for Amp, 0.05 mg/ml for Chlo, 0.50 mM for Cr(VI) and Mn(II). Asterisk means significant difference between two groups (T tests, p < 0.05)
Co-tolerance of different strains to Cr(VI) and ampicillin in TSB medium
| Amp mg/ml | Cr(VI) mM | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.8 | 1.6 | 3.2 | 4 | 4.8 | 6 | 8 | 10 | ||
| LZ-01 | 0.1 | + | + | + | + | + | + | + | + |
| 0.2 | + | + | + | + | + | + | + | + | |
| 0.4 | + | + | + | + | + | + | – | – | |
| 0.5 | + | + | + | + | + | + | – | – | |
| 0.6 | + | + | + | + | + | + | – | – | |
| 0.75 | + | + | + | + | + | + | – | – | |
| 1.0 | + | + | + | – | – | – | – | – | |
| 1.25 | + | + | – | – | – | – | – | – | |
|
| 0.1 | + | + | + | + | + | + | – | – |
| 0.2 | + | – | – | – | – | – | – | – | |
| 0.4 | – | – | – | – | – | – | – | – | |
|
| 0.1 | + | + | – | – | – | – | – | – |
| 0.2 | + | – | – | – | – | – | – | – | |
| 0.4 | – | – | – | – | – | – | – | – | |
| CB | 0.2 | + | + | + | + | + | + | + | – |
| 0.4 | + | + | + | + | + | – | – | – | |
| 0.5 | + | + | + | + | – | – | – | – | |
| 0.6 | + | + | + | + | – | – | – | – | |
| 0.75 | + | + | – | – | – | – | – | – | |
| 1.0 | + | – | – | – | – | – | – | – | |
| 1.25 | + | – | – | – | – | – | – | – | |
| CA | 0.2 | + | + | + | + | + | + | – | – |
| 0.4 | + | + | + | + | + | – | – | – | |
| 0.5 | + | + | + | + | – | – | – | – | |
| 0.6 | + | + | + | – | – | – | – | – | |
| 0.75 | + | + | – | – | – | – | – | – | |
| 1.0 | + | – | – | – | – | – | – | – | |
| 1.25 | + | – | – | – | – | – | – | – | |
Fig. 5Induction effect of ampicillin and Cr(VI) on different strains. The induced level of Amp was 0.15 mg/ml for strain LZ-01, strain CA and CB; for mutant stain was 0.05 mg/ml. The induced level of Cr(VI) was 0.50 mM for all strains. Asterisk means significant difference between two groups (T tests, p < 0.05)
The expression level change of four PBPs genes under ampicillin stress (0.05 mg/ml) in S. aureus LZ-01 determined by qPCR
| Genes | LZ-01 |
|
| CB | CA |
|---|---|---|---|---|---|
|
| 3.88 ± 0.22 | 1.13 ± 0.15 | 1.07 ± 0.11 | 2.51 ± 0.16 | 2.44 ± 0.08 |
|
| 2.02 ± 0.13 | 0.76 ± 0.07 | 1.38 ± 0.10 | 1.35 ± 0.09 | 1.63 ± 0.13 |
|
| 2.71 ± 0.17 | 0.85 ± 0.12 | 0.26 ± 0.05 | 1.55 ± 0.10 | 1.47 ± 0.09 |
|
| 3.32 ± 0.23 | 1.33 ± 0.05 | 0.45 ± 0.07 | 2.23 ± 0.12 | 1.89 ± 0.11 |